Danaher Names Julie Sawyer Montgomery as CEO, Effective Immediately…

Event summary

Julie Sawyer Montgomery assumes roles of President and CEO of Danaher Corporation, effective October 1, 2026.
She joins Danaher's Board of Directors, following a planned succession announced on August 3, 2026.
Montgomery has held roles in commercial operations, R&D, and business leadership since joining Danaher in 2017.
Rainer Blair will serve as senior advisor until March 31, 2027 to ensure a seamless transition.

The big picture

Danaher's leadership change comes at a time when the life sciences and diagnostics sectors are under pressure to deliver faster, more accurate diagnostics and reduce the time and cost of developing life-changing therapies. Montgomery's background in advancing innovation and commercial excellence positions her to navigate these challenges, but the success of her tenure will depend on her ability to maintain operational excellence and drive share gain in a competitive market.

What we're watching

Strategic Continuity: How Montgomery will leverage her experience in commercial operations and R&D to drive innovation and share gain.
Operational Excellence: Whether Montgomery can sustain the optimization of the Danaher Business System to strengthen operating performance.
Transition Impact: The pace at which Rainer Blair's advisory role will influence the leadership transition and strategic direction.